Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Problems with de novo transcriptome assembly using 454 Titanium series

    Hi,

    I am trying to do a de novo transcriptome assembly for a non-model organism using 454 GS FLX Titanium series. I have 656878 reads with average length of 377 base pairs which after cleaning, masking and assembling using TGICL (uses CAP3 to assemble), I have 87282 contigs and 317205 singletons. My contigs have an average length of 700 bp and an average coverage depth of 1.9.

    I am afraid that the coverage is very low and am not getting enough contigs due to the large number of singletons. Any ideas on how can I improve my assembly? Are these problems inherent to the TGICL assembly program or should I use some other software like MIRA? Are there any other parameters that I should look at to give me a better idea about the quality of my contigs and assembly?

    Thanks

  • #2
    Hi ankitgupta.iitg,

    If you've not heard previously, 454 Life Sciences will shortly launch a new transcriptome assembler as part of our next product update. I think you will find this new tool extremely useful in your de novo transcriptome assembly efforts. For more details please see the following:



    In the meantime, I'd recommend following up with your Roche representative. One of our bioinformatics Regional Applications Consultants should be able to lend a hand with your question.

    Best regards,
    Jason

    Technical Product Manager
    454 Life Sciences, A Roche Company
    Technical Product Manager
    454 Life Sciences, A Roche Company

    Comment

    Latest Articles

    Collapse

    • seqadmin
      Understanding Genetic Influence on Infectious Disease
      by seqadmin




      During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

      Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
      09-09-2024, 10:59 AM
    • seqadmin
      Addressing Off-Target Effects in CRISPR Technologies
      by seqadmin






      The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
      08-27-2024, 04:44 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by seqadmin, Today, 06:25 AM
    0 responses
    13 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, Yesterday, 01:02 PM
    0 responses
    12 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 09-18-2024, 06:39 AM
    0 responses
    14 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 09-11-2024, 02:44 PM
    0 responses
    14 views
    0 likes
    Last Post seqadmin  
    Working...
    X